Paying physicians to prescribe generic drugs and follow-on biologics in the United States

PLoS Medicine
Ameet SarpatwariAaron S Kesselheim

Abstract

Aaron Kesselheim and colleagues examine potential strategies to promote greater prescribing of generic drugs and follow-on biologics.

References

Jun 19, 1998·Clinical Pharmacology and Therapeutics·G Levy
Feb 24, 2001·The Annals of Pharmacotherapy·K A Hope, D E Havrda
May 1, 2002·JAMA : the Journal of the American Medical Association·Karen E LasserDavid H Bor
Oct 29, 2004·The New England Journal of Medicine·David Blumenthal
Oct 19, 2007·The Cochrane Database of Systematic Reviews·M A O'BrienE L Harvey
Dec 4, 2008·JAMA : the Journal of the American Medical Association·Aaron S KesselheimWilliam H Shrank
Dec 10, 2008·Archives of Internal Medicine·Michael A FischerJoel S Weissman
Oct 22, 2010·Journal of the American Medical Informatics Association : JAMIA·Shane P StennerKevin B Johnson
Jan 6, 2011·The Annals of Pharmacotherapy·William H ShrankNiteesh K Choudhry
Mar 26, 2011·The American Journal of Medicine·William H ShrankNiteesh K Choudhry
Apr 28, 2011·The Annals of Pharmacotherapy·Christine L Fitzgerald, Mercedes P Jacobson
Oct 25, 2011·The American Journal of Medicine·Michael A FischerWilliam H Shrank
Jan 14, 2012·Therapeutics and Clinical Risk Management·Bryan A Liang, Timothy Mackey
Jun 6, 2012·Archives of Internal Medicine·Bo WangNiteesh K Choudhry
Dec 12, 2012·The New England Journal of Medicine·Janet WoodcockLawrence X Yu
Oct 9, 2013·Health Affairs·Francis MegerlinJean-Hugues Trouvin
Jan 22, 2014·Nature Reviews. Drug Discovery·Henry GrabowskiMaria Salgado
Jan 23, 2014·JAMA : the Journal of the American Medical Association·Nicholas S DowningJoseph S Ross
Mar 29, 2014·The New England Journal of Medicine·David HuntSiddharthan Chandran

❮ Previous
Next ❯

Citations

Nov 23, 2017·Clinical Pharmacology and Therapeutics·Ameet SarpatwariAaron S Kesselheim
Jan 30, 2020·The New England Journal of Medicine·Dhruv KhullarPeter B Bach
Sep 11, 2019·European Heart Journal. Cardiovascular Pharmacotherapy·Juan Tamargo, Giuseppe Rosano
Jul 10, 2020·PloS One·Sachiko OzawaVictor S Pribluda
Feb 28, 2018·Journal of Managed Care & Specialty Pharmacy·Ahmed U MishukRichard Hansen
Nov 14, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Ameet SarpatwariAaron S Kesselheim
Dec 11, 2019·Pharmacy : Journal of Pharmacy, Education and Practice·Kennedy AbugaIsaac Kibwage
Sep 13, 2017·The Milbank Quarterly·Olivier J WoutersMartin McKEE

❮ Previous
Next ❯

Software Mentioned

Excellus BlueShield
ProPublica

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Richard G Frank
Topics in Hospital Pharmacy Management
C D HeplerR A Freeman
Family Practice Management
Mark Ebell
© 2021 Meta ULC. All rights reserved